Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2003
12/18/2003WO2003104809A1 Solid phase substrate for immobilizing biomolecules
12/18/2003WO2003104808A1 New probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003104806A1 Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same
12/18/2003WO2003104805A1 Bioassay unit and substrate for bioassay
12/18/2003WO2003104804A1 Methods of searching for substance having antidiabetic effect
12/18/2003WO2003104803A2 Method for mapping and eliminating t-cell epitopes
12/18/2003WO2003104802A1 Electrospray tandem mass spectrometry for newborn screening
12/18/2003WO2003104800A1 Identification of proteins present in complex mixtures
12/18/2003WO2003104798A1 Method for analysing a working fluid using impedance spectroscopy
12/18/2003WO2003104797A1 Methods and apparatus for harvesting vaccine from eggs
12/18/2003WO2003104796A1 Portable vehicle exhaust analyzer module
12/18/2003WO2003104795A1 Analysis of mercury containing samples
12/18/2003WO2003104794A1 A method for analyzing the spatial distribution of a chemical substance retained by a biological matter
12/18/2003WO2003104789A1 MULTIFUNCTIONAL BIOSENSOR BASED ON ZnO NANOSTRUCTURES
12/18/2003WO2003104788A1 Extracellular potential measuring device and method for fabricating the same
12/18/2003WO2003104787A1 Sensor and sensing method for detection and process control
12/18/2003WO2003104785A1 Measurement and monitoring system of dairy stock and plant
12/18/2003WO2003104782A1 Directional coupler sensor for measuring moisture of hair
12/18/2003WO2003104778A1 Methods for identifying ligands using competitive binding <1>h nmr experiments
12/18/2003WO2003104777A1 Method and apparatus for determining wood parameters, including grain angle
12/18/2003WO2003104776A1 Method and apparatus for determining wood parameters, including grain length
12/18/2003WO2003104773A1 Apparatus for measuring green-speed
12/18/2003WO2003104772A1 A disposable cartridge for characterizing particles suspended in a liquid
12/18/2003WO2003104771A1 Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells
12/18/2003WO2003104770A2 A disposable cartridge for characterizing particles suspended in a liquid
12/18/2003WO2003104765A2 Total organic carbon (toc) analyzer
12/18/2003WO2003104764A2 Automated immunoassay cassette, apparatus and mehtod
12/18/2003WO2003104762A2 Protein micro-arrays and multi-layered affinity interaction detection
12/18/2003WO2003104761A2 Measurement of melanocortin peptides and uses thereof
12/18/2003WO2003104752A2 Water cut rate of change analytic method
12/18/2003WO2003104685A2 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof
12/18/2003WO2003104572A1 Water supply monitoring for contaminant detection
12/18/2003WO2003104496A1 Type i interferon-inducible proteins to detect viral infection
12/18/2003WO2003104490A2 Method for the simultaneous detection of hybridization and vaccination reactions and diagnostic uses thereof
12/18/2003WO2003104488A1 Eef1a2 for use in the prognosis, diagnosis and treatment of cancer
12/18/2003WO2003104486A1 Method of selectively measuring triglycerides
12/18/2003WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003WO2003104484A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators
12/18/2003WO2003104482A1 Signals and molecular species involved in senescence
12/18/2003WO2003104480A1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor
12/18/2003WO2003104479A2 Identification of inhibitors of mitosis
12/18/2003WO2003104478A2 Detection of rna structural elements
12/18/2003WO2003104466A1 Treatment of vascular dysfunction and alzheimer's disease
12/18/2003WO2003104460A1 Pigment protein
12/18/2003WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease
12/18/2003WO2003104454A1 Novel oxidase
12/18/2003WO2003104447A1 Fluorescent detection of peroxidase enzymes
12/18/2003WO2003104442A1 Methods of regulating differentiation in stem cells
12/18/2003WO2003104434A2 A method to amplify variable sequences without imposing primer sequences
12/18/2003WO2003104431A2 Transgenic mammals expressing polyglutamine
12/18/2003WO2003104426A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003WO2003104424A2 Novel molecular conjugates for signal amplification
12/18/2003WO2003104421A2 Immunocapture and functional assay for mitochondrial f1/f0 atpase
12/18/2003WO2003104415A2 Method to screen ligands using eukaryotic cell display
12/18/2003WO2003104384A1 Reactor systems having a light-interacting component
12/18/2003WO2003104363A2 Determining fluid composition from fluid properties
12/18/2003WO2003104282A2 Immunoadhesin comprising a glycoprotein vi domain
12/18/2003WO2003104263A2 Cytokines and cytokine receptors with reduced immunogenicity
12/18/2003WO2003104259A2 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF
12/18/2003WO2003104252A1 Biodetection method
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104181A2 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
12/18/2003WO2003103864A1 Method and system for reducing landfill methane emissions
12/18/2003WO2003103771A1 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103709A2 Modulation of bone development
12/18/2003WO2003103676A2 Method of treating cancer using kinase inhibitors
12/18/2003WO2003103662A2 Inhibitors of glycoprotein vi
12/18/2003WO2003103613A2 Induction of insulin expression
12/18/2003WO2003103607A2 Viral envelope mediated fusion assay
12/18/2003WO2003103606A2 Methods and compositions for treating and diagnosing diabetes
12/18/2003WO2003103601A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103597A2 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003WO2003103593A2 Secretases related to alzheimer's dementia
12/18/2003WO2003103579A2 High-throughput methods and systems for screening of compounds to treat/prevent kidney disorders
12/18/2003WO2003103481A2 Methods for detecting b. anthracis infection
12/18/2003WO2003103478A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
12/18/2003WO2003103399A1 Method and arrangement related to a dough forming
12/18/2003WO2003087835A8 Haptoglobin fragments diagnostic of alzheimers disease
12/18/2003WO2003085752A3 Molehole embedded 3-d crossbar architecture used in electrochemical molecular memory device
12/18/2003WO2003083463A3 Apparatus and method for electrochemical detection and control of inorganic scale
12/18/2003WO2003078050A3 A building block forming a c-c bond upon reaction
12/18/2003WO2003076937A3 Apparatus and methods for analyte measurement and immunoassay
12/18/2003WO2003074549A3 Assay for anti-ingap antibodies
12/18/2003WO2003067904A3 High-throughput cell identification and isolation method and apparatus
12/18/2003WO2003067263A3 Assay
12/18/2003WO2003067210A3 Methods and compositions for detecting the activation state of the multiple proteins in single cells
12/18/2003WO2003064994A3 Methods of collecting and analyzing human breath
12/18/2003WO2003060653A3 Method and/or system for analyzing biological samples using a computer system
12/18/2003WO2003058248A3 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
12/18/2003WO2003058205A3 Methods of identifying putative effector proteins
12/18/2003WO2003057911A3 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
12/18/2003WO2003057159A3 Psoriasin expression by breast epithelial cells
12/18/2003WO2003056031A3 Method and kit for detecting alkaline sphingomyelinase
12/18/2003WO2003052382A3 Integrated protein affinity capture centrifugation device
12/18/2003WO2003051917A3 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/18/2003WO2003050535A3 Method for determining the influence of non-physiological compounds the derivatives and decomposition products thereof on organisms organs and cells
12/18/2003WO2003049599A3 Methods and compositions for the diagnosis of asthma
12/18/2003WO2003048784A3 Internal standards for sphingolipids for use in mass spectrometry